HGHCX Performance — The Hartford Healthcare Fund, Class C

Data updated: 2026-09-29

HGHCX returned +4.40% year to date and +31.11% over one year to Jul 2026. Annualised returns are +6.63% over 3 years and +1.42% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $121, against $137 for the category, and to $131 over one year, against $137. Volatility over the past three years was 14.88% a year. In the 12 months to Jul 2026 the fund lost a net $152.1M, and assets reached $772.21M.

HGHCX Growth of $100

What $100 invested in The Hartford Healthcare Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.

PeriodHGHCXCategory average
1 year (Aug 2025 – Jul 2026)$131$137
3 years (Aug 2023 – Jul 2026)$121$137
5 years (Aug 2021 – Jul 2026)$107$121
Since data start (Aug 2019 – Jul 2026)$164$183

HGHCX Trailing Returns

Total returns to Jul 2026, from SEC N-PORT.

PeriodTotal return
YTD+4.40%
1 year+31.11%
3 years (annualised)+6.63%
5 years (annualised)+1.42%

HGHCX Annual Returns

Calendar-year total returns of The Hartford Healthcare Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jul)+4.40%
2025+14.66%
2024−0.79%
2023+3.00%
2022−12.42%
2021+9.12%
2020+21.66%
2019 (Aug–Dec)+15.34%

HGHCX Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026−0.5%+1.7%−6.3%+0.7%+2.3%+7.6%−0.5%—————
2025+5.9%−1.8%−3.6%−1.8%−5.8%+1.7%−3.3%+5.0%+3.9%+6.1%+9.7%−1.0%
2024+1.3%+3.6%+2.0%−4.4%+2.1%+1.9%+2.4%+6.0%−2.8%−5.6%0.0%−6.6%
2023−0.7%−4.7%+1.5%+4.0%−2.7%+4.3%−0.5%−1.4%−4.3%−3.8%+6.5%+5.6%
2022−10.8%+0.3%+3.0%−7.8%−0.4%−1.7%+4.8%−5.8%−3.5%+7.5%+4.8%−1.9%
2021+1.6%−2.1%−0.2%+4.5%0.0%+3.8%+1.2%+2.3%−5.5%+2.7%−5.1%+6.4%
2020−2.0%−5.1%−7.1%+14.0%+6.1%−0.3%+3.4%+3.4%−1.0%−2.3%+8.2%+4.2%
2019———————−1.6%−1.7%+6.0%+7.7%+4.3%

HGHCX Risk

Risk measures from monthly returns over Aug 2023 – Jul 2026.

  • 3-year volatility (annualised): 14.88%
  • 3-year Sharpe ratio: 0.14 (vs 4.5% risk-free rate)
  • Best month: +9.69% (Nov 2025)
  • Worst month: −6.61% (Dec 2024)

HGHCX Fund Flows

Monthly money in and out of The Hartford Healthcare Fund, from SEC Form N-PORT.

  • 12-month net flow: −$152.1M
  • 12-month gross sales (incl. reinvestments): $78.0M
  • Sales ÷ redemptions: 0.34×
MonthSalesRedemptionsNet flow
Jul 2026$4.2M$9.0M−$4.8M
Jun 2026$3.2M$12.0M−$8.8M
May 2026$2.8M$15.7M−$12.9M
Apr 2026$2.3M$17.6M−$15.3M
Mar 2026$3.7M$50.6M−$46.9M
Feb 2026$4.3M$15.4M−$11.1M
Jan 2026$7.3M$14.7M−$7.4M
Dec 2025$34.0M$17.9M$16.1M
Nov 2025$5.1M$15.4M−$10.3M
Oct 2025$3.2M$19.5M−$16.3M
Sep 2025$3.3M$20.6M−$17.3M
Aug 2025$4.4M$21.6M−$17.2M

HGHCX Assets Under Management

Net assets of The Hartford Healthcare Fund by report date, from SEC N-PORT filings.

Report dateNet assets
2026-07-31$772.21M
2026-04-30$729.19M
2026-01-31$834.13M
2025-10-31$800.04M
2025-07-31$737.39M
2025-04-30$861.87M
2025-01-31$983.40M
2024-10-31$1.04B
2024-07-31$1.10B
2024-04-30$1.07B
2024-01-31$1.15B
2023-10-31$1.07B

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.